238 related articles for article (PubMed ID: 31880484)
1. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA
Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X
Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484
[No Abstract] [Full Text] [Related]
2. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
3. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
4. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Gong J; Zhang H; He L; Wang L; Wang J
Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non-small cell lung cancer.
Chen D; Li Y; Wang Y; Xu J
Genes Genomics; 2021 Feb; 43(2):183-194. PubMed ID: 33537917
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
Lin L; Gu ZT; Chen WH; Cao KJ
Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
[TBL] [Abstract][Full Text] [Related]
11. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
[TBL] [Abstract][Full Text] [Related]
12. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
Wang H; Wang J; Liang CF; Zhou T
Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
[TBL] [Abstract][Full Text] [Related]
13. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
[TBL] [Abstract][Full Text] [Related]
14. Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues.
Esfandi F; Taheri M; Omrani MD; Shadmehr MB; Arsang-Jang S; Shams R; Ghafouri-Fard S
BMC Cancer; 2019 Mar; 19(1):222. PubMed ID: 30866866
[TBL] [Abstract][Full Text] [Related]
15. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
[TBL] [Abstract][Full Text] [Related]
16. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
Tan J; Yang L
Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
[TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
Song H; Li H; Ding X; Li M; Shen H; Li Y; Zhang X; Xing L
Int J Oncol; 2020 Dec; 57(6):1333-1347. PubMed ID: 33174014
[TBL] [Abstract][Full Text] [Related]
19. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
20. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
